Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Satish K. Kedia, Nikhil Ahuja, Patrick J. Dillon, Andrew Jones, Santosh Kumar & Sanjaya Satapathy. (2023) Efficacy of Extended-Release Injectable Naltrexone on Alcohol Use Disorder Treatment: A Systematic Review. Journal of Psychoactive Drugs 55:2, pages 233-245.
Read now
Read now
Susan E. Collins, Mark H. Duncan, Brian F. Smart, Andrew J. Saxon, Daniel K. Malone, T. Ron Jackson & Richard K. Ries. (2015) Extended-Release Naltrexone and Harm Reduction Counseling for Chronically Homeless People With Alcohol Dependence. Substance Abuse 36:1, pages 21-33.
Read now
Read now
Robin C Wackernah, Matthew J Minnick & Peter Clapp. (2014) Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment. Substance Abuse and Rehabilitation 5, pages 1-12.
Read now
Read now
Articles from other publishers (16)
Siobhan Botwright, Jiratorn Sutawong, Pritaporn Kingkaew, Thunyarat Anothaisintawee, Saudamini Vishwanath Dabak, Chotika Suwanpanich, Nattiwat Promchit, Roongnapa Kampang & Wanrudee Isaranuwatchai. (2023) Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence. BMC Public Health 23:1.
Crossref
Crossref
Michael F. Weaver, Judy H. Hong & Adrienne Gilmore-Thomas. 2023. Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy. Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy
317
327
.
Jan van Amsterdam, Peter Blanken, Renske Spijkerman, Wim van den Brink & Vincent Hendriks. (2022) The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review. Alcohol and Alcoholism.
Crossref
Crossref
Natalia Kučić, Valentino Rački, Roberta Šverko, Toni Vidović, Irena Grahovac & Jasenka Mršić-Pelčić. (2021) Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells. International Journal of Molecular Sciences 22:16, pages 8429.
Crossref
Crossref
Scott A. Simpson & Julie Taub. 2021. Behavioral Emergencies for Healthcare Providers. Behavioral Emergencies for Healthcare Providers
77
88
.
Leanne Trick & Bernard Le Foll. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
123
139
.
Angela K. Stevens, Brittany E. Blanchard, Molin Shi & Andrew K. Littlefield. 2020. The Wiley Encyclopedia of Health Psychology. The Wiley Encyclopedia of Health Psychology
437
444
.
Przemyslaw Bienkowski, Marcin Wojnar, Pawel Mierzejewski, Jerzy Samochowiec, Boguslaw Habrat, Marek Jarema & Janusz Rybakowski. (2019) Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines from the Section of Pharmacotherapy of Polish Society for Research on Addictions (PTBU) and the Section of Psychopharmacology of Polish Psychiatric Association (PTP) – 2019 update. Pharmacotherapy in Psychiatry and Neurology 35:2, pages 95-110.
Crossref
Crossref
Andrew M. Kiselica & Amy Duhig. 2019. Cannabis Use Disorders. Cannabis Use Disorders
245
252
.
Adrián Viudez-Martínez, María S García-Gutiérrez, Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez & Jorge Manzanares. (2018) Effects of cannabidiol plus naltrexone on motivation and ethanol consumption. British Journal of Pharmacology 175:16, pages 3369-3378.
Crossref
Crossref
E. T. Goh & M. Y. Morgan. (2017) Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary Pharmacology & Therapeutics 45:7, pages 865-882.
Crossref
Crossref
Michael Soyka & Jochen Mutschler. (2016) Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 148-161.
Crossref
Crossref
Ajaykumar N. Sharma, Ashish Pise, Jay N. Sharma & Praveen Shukla. (2014) Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats. Metabolic Brain Disease 30:3, pages 719-730.
Crossref
Crossref
Ajaykumar N. Sharma, Ashish Pise, Jay N. Sharma & Praveen Shukla. (2014) Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats. Metabolic Brain Disease 30:3, pages 659-667.
Crossref
Crossref
Michal Bajo, Samuel G. Madamba, Marisa Roberto, Yuri A. Blednov, Vasudeva N. Sagi, Edward Roberts, Kenner C. Rice, R. Adron Harris & George R. Siggins. (2014) Innate immune factors modulate ethanol interaction with GABAergic transmission in mouse central amygdala. Brain, Behavior, and Immunity 40, pages 191-202.
Crossref
Crossref
Audrey MorissetteMDMD, Clairélaine Ouellet-PlamondonMDMD & Didier Jutras-AswadMDMD. (2014) Le craving comme symptôme central de la toxicomanie : de ses fondements neurobiologiques à sa pertinence clinique. Santé mentale au Québec 39:2, pages 21-37.
Crossref
Crossref